Skip to main content

Table 1 Baseline characteristics of the 14 participants with exercise induced bronchoconstriction

From: An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction

Subject

BMI (kg/m2)

Age

FEV1 (L)

FEV1% predicted

FVC (liter)

FEV1% predicted

Max fall FEV1 in ECT (%)

RDR mannitol (%/mg)

PD15 mannitol

MCT positive

         

A

39.7

 

3.24

83.5

3.98

84.5

15.7

0.059

293

B

25.0

 

2.34

128.6

2.86

134.9

29.1

0.034

569

C

16.4

 

2.02

125.3

2.56

133.3

61.7

0.120

133

D

17.2

 

3.09

109.2

3.97

116.8

48.7

0.155

102

E

36.4

 

2.43

92.4

2.82

89.5

16.0

0.037

512

F

29.7

 

3.54

101.4

4.89

115.9

29.7

0.313

49

G

25.8

 

4.45

100

5.82

107.6

22.5

0.039

475

Mean ± SD or median (IQR)

25.8 (19.1)

14.1 ± 3.5

3.01 ± 0.83

105.8 ± 16.5

3.84 ± 1.20

111.8 ± 19.6

29.1 (32.7)

0.059 (0.118)

293 (410)

MCT negative

         

H

15.5

 

1.92

85.3

2.44

90.4

46.8

0.034

 

I

35.0

 

4.52

113.6

5.02

103.9

20.8

0.030

 

J

37.1

 

2.87

101.4

3.62

105.5

16.9

0.020

 

K

30.0

 

3.41

104.9

4.85

130

42.9

0.075

 

L

30.7

 

3.69

100.5

4.64

104.5

17.6

0.020

 

M

35.2

 

5.78

136.3

7.23

140.4

18.3

0.030

 

N

14.8

 

2.56

133.3

3.08

134.5

17.9

0

 

Mean ± SD or (Median)

30.7 (19.7)

14.1 ± 3

3.53 ± 1.29

110.8 ± 18.5

4.41 ± 1.57

115.6 ± 19

18.3 (25.3)

0.030 (0.014)

 

p-value

0.45

ns

0.22

0.24

0.31

0.45

0.29

0.03

 
  1. ns = non significant.